We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
David Penson

David F Penson MD, MPH

Hamilton and Howd Chair in Urologic Oncology; Professor of Urologic Surgery and Medicine; Director, Center for Surgical Quality and Outcomes Research, Vanderbilt University Medical Center, Nashville, TN

Recent Contributions to PracticeUpdate:

  1. Financial Margins for Prostate Cancer Surgery
  2. Variation and Predictors of Surgical Case Costs Among Urologists
  3. Lower Urinary Tract Symptoms and Risk of Bladder Cancer in Men
  4. Surgical Outcomes Monitoring Programs and Care Quality Measures
  5. Neoadjuvant Chemotherapy Cost-Effective in Muscle-Invasive Bladder Cancer
  6. Overdiagnosis and Overtreatment: Evaluation of What Physicians Tell Their Patients About Screening Harms
  7. Affordable Care Act—Changes Are Coming for Urologists, Ready or Not
  8. How Will the Affordable Care Act Affect Treatment of Urologic Cancers?
  9. Increased Subsequent Risk of Erectile Dysfunction in Patients With Irritable Bowel Syndrome: A Nationwide Population-Based Cohort Study
  10. High Risk for Other-Cause Mortality in Older Men With Prostate Cancer

Most Read This Week

Recently Updated